Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4 T cells as predictors for response to integrin α4β7-blocking therapy in inflammatory bowel disease.
Gastroenterology
View this publicationGastroenterology
View this publicationScientific reports
View this publicationNature structural & molecular biology
View this publicationScience advances
View this publicationInnere Medizin (Heidelberg, Germany)
View this publicationPharmaceutics
View this publicationThe New England journal of medicine
View this publicationNature communications
View this publicationThe Journal of nutrition
View this publicationJournal of the American Heart Association
View this publication